Alzheimer’s just got a new diagnostic standard in 2024 — clinical symptoms alone aren't enough. Now, biomarker-based evidence is essential for diagnosis. But here’s the challenge: early detection is still a blind spot globally, with even the FDA yet to approve a blood-based test for AD.
Enter Taiwan’s innovation powerhouses!
From cutting-edge blood tests to advanced brain imaging and EEG-based tech, these 7 rising stars are paving the path toward early, precise, and accessible Alzheimer’s screening. 
Meet the early detection pioneers:

• MagQu
• AcroViz Technology
• APRINOIA Therapeutics
• Reliance Biosciences
• Instant NanoBiosensors
• HippoScreen Neurotech
• Power-Stem

These companies are diving into the untapped blue ocean of Alzheimer’s diagnostics, helping us detect cognitive decline before it’s too late.
Full story here:
https://news.gbimonthly.com/tw/magazine/article_show.php?num=75830
#Alzheimers #EarlyDetection #BrainHealth #BloodBiomarkers #NeuroTech #TaiwanBiotech #Globalbio #InnovationNews #DementiaAwareness
Follow #Globalbio for more breakthroughs in biotech and medical innovation!